Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321 | ISIN: INE010B01027 | Industry: Pharmaceuticals
| Falling Comet
873.5000 7.20 (0.83%)
NSE Apr 07, 2026 15:31 PM
Volume: 682.2K
 

logo
Zydus Lifesciences Ltd.
21 Nov 2019
873.50
0.83%
Business Line
Cadila Healthcare said it has received approval from the US health regulator to market Isosorbide Dinitrate tablets used to prevent attacks of chest p
Zydus Lifesciences Ltd. is trading below all available SMAs
USFDA approves Zydus Cadila's Dinitrate tablets, Desonide Cream
Business Line | 21 Nov 2019 1 more
More from Zydus Lifesciences Ltd.
Recommended
Market closes higher, buoyed by gains in metal and IT stocks
Trendlyne Marketwatch | 07 Apr 2026, 03:36PM
IPO pipeline stays active, while post-listing performance remains subdued
| 06 Apr 2026, 05:47PM
Earnings Call Transcript - Cadila Healthcare
| 14 Feb 2020